Anti-hypoxia Activity of the Novel NO Donor Acetyl Ferulic Isosorbide Mononitrate in Acute High-Altitude Hypoxia Mice

Biological & Pharmaceutical Bulletin
Peng-Cheng FanZheng-Ping Jia

Abstract

Nitric oxide (NO) may act as either a pro-oxidant or an antioxidant in biological systems. Previous work has found inhalation of NO improved survival in a high altitude rat model. NO donor isosorbide mononitrate derivants might have a protective effect against hypoxia. We synthesized a series of isosorbide mononitrate derivant compounds to test their anti-hypoxia activities. Normobaric hypoxia and hypobaric hypoxia models were used to study the protective role of NO donor in mice. The results showed isosorbide mononitrate derivants had protective effects in hypoxia mice. Among those compounds, acetyl ferulic isosorbide mononitrate (AFIM) was the most effective. It prolonged the survival time during the normobaric hypoxia test. It decreased malondialdehyde (MDA) and H2O2 in hypobaric hypoxia mice. The antioxidase activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase (CAT) remained in normal ranges in the AFIM group. As a sign of mitochondrial dysfunction, the activities of ATPase were down regulated in mice under hypobaric hypoxia conditions. AFIM also protected ATPase activities. The protective effects of AFIM might come from a sustained NO supply and the release of acetyl ferulic acid with anti...Continue Reading

References

May 1, 1978·Analytical Biochemistry·M Mihara, M Uchiyama
Jul 1, 1984·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·S OhtaM Shinoda
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D A WinkJ B Mitchell
Mar 7, 1996·The New England Journal of Medicine·U ScherrerP Bärtsch
Jun 1, 1996·The American Journal of Physiology·J ChangJ R Michael
Feb 24, 2001·Wilderness & Environmental Medicine·A OmuraT Jennings
Nov 1, 2001·Respiratory Research·K A FaganD M Rodman
Jun 6, 2002·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·E Krampl
Jul 22, 2004·High Altitude Medicine & Biology·Peter H Hackett, Robert C Roach
Feb 11, 2005·Journal of Applied Physiology·Peter BärtschErik R Swenson
Mar 16, 2005·Respiratory Physiology & Neurobiology·Takeshi IshizakiAkio Sakai
Jul 19, 2005·Journal of Applied Physiology·Brian D HoitCynthia M Beall
Jun 23, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·D Venkat RatnamM N V Ravi Kumar
May 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Cynthia M Beall
Nov 1, 2007·Proceedings of the National Academy of Sciences of the United States of America·S C ErzurumC M Beall
Dec 14, 2007·Wilderness & Environmental Medicine·Fernando A MoragaCorina Barriento
Mar 4, 2008·American Journal of Physiology. Heart and Circulatory Physiology·B A KaufmannH P Brunner-La Rocca
Oct 7, 2008·Chemical Research in Toxicology·Magdalena A LamMichael J Davies
Apr 27, 2010·Progress in Cardiovascular Diseases·Chris ImrayRobert Roach
May 4, 2011·Respiratory Physiology & Neurobiology·Lorna G MooreColleen G Julian
Dec 14, 2011·Annals of Emergency Medicine·Rawle A SeupaulThomas W Emmett
Mar 3, 2012·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·Matiram Pun
Sep 5, 2012·Journal of Travel Medicine·Neil D RitchieW T Andrew Todd
Dec 13, 2012·Neuropharmacology·Ming-Tao YangWen-Mei Fu

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.